These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 11712810)

  • 21. Relationship of p53 with other oncogenes, cytokines and systemic lupus erythematosus activity.
    Miret C; Molina R; Filella X; García-Carrasco M; Claver G; Ingelmo M; Ballesta A; Font J
    Tumour Biol; 2003; 24(4):185-8. PubMed ID: 14654712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proinflammatory cytokines in inactive lupus erythematosus patients].
    Lesiak A; Sysa-Jedrzejowska A; Narbutt J; Lukamowicz J; Robak E; Wozniacka A
    Przegl Lek; 2005; 62(9):838-42. PubMed ID: 16541713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
    Tinazzi E; Puccetti A; Gerli R; Rigo A; Migliorini P; Simeoni S; Beri R; Dolcino M; Martinelli N; Corrocher R; Lunardi C
    Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics.
    Omdal R; Mellgren SI; Koldingsnes W; Jacobsen EA; Husby G
    J Rheumatol; 2002 Mar; 29(3):482-6. PubMed ID: 11908560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus.
    Sabry AA; Elbasyouni SR; Kalil AM; Abdel-Rahim M; Mohsen T; Sleem A
    Nephrology (Carlton); 2006 Aug; 11(4):329-35. PubMed ID: 16889573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.
    López P; Gómez J; Prado C; Gutiérrez C; Suárez A
    J Rheumatol; 2008 Aug; 35(8):1559-66. PubMed ID: 18597405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.
    Gattorno M; Picco P; Barbano G; Stalla F; Sormani MP; Buoncompagni A; Gusmano R; Borrone C; Pistoia V
    J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating levels of soluble Fas ligand and soluble Fas in patients with chronic obstructive pulmonary disease.
    Takabatake N; Nakamura H; Inoue S; Terashita K; Yuki H; Kato S; Yasumura S; Tomoike H
    Respir Med; 2000 Dec; 94(12):1215-20. PubMed ID: 11192958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation.
    Waszczykowska E; Robak E; Wozniacka A; Narbutt J; Torzecka JD; Sysa-Jedrzejowska A
    Mediators Inflamm; 1999; 8(2):93-100. PubMed ID: 10704146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine regulation of apoptosis and Bcl-2 expression in lymphocytes of patients with systemic lupus erythematosus.
    Graninger WB; Steiner CW; Graninger MT; Aringer M; Smolen JS
    Cell Death Differ; 2000 Oct; 7(10):966-72. PubMed ID: 11279543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
    al-Janadi M; Raziuddin S
    J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum soluble Fas levels in patients with autoimmune rheumatic diseases.
    Sahin M; Aydintug O; Tunc SE; Tutkak H; Naziroğlu M
    Clin Biochem; 2007 Jan; 40(1-2):6-10. PubMed ID: 17056024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response.
    Lacki JK; Leszczynski P; Kelemen J; Müller W; Mackiewicz SH
    J Med; 1997; 28(1-2):99-107. PubMed ID: 9249616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The importance of determination of interleukin-10 in the blood of patients with systemic lupus erythematosus].
    Scudla V; Horák P; Faltýnek L; Pospísil Z; Budíková M; Hermanová Z
    Cas Lek Cesk; 1998 Jan; 137(2):44-7. PubMed ID: 9511265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of the roles of cytokines and apoptosis in dilated and hypertrophic cardiomyopathies.
    Buzás K; Megyeri K; Hõgye M; Csanády M; Bogáts G; Mándi Y
    Eur Cytokine Netw; 2004; 15(1):53-9. PubMed ID: 15217753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM; Taher TE; Isenberg DA; Mageed RA
    Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus.
    Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
    J Rheumatol; 2007 Jul; 34(7):1580-4. PubMed ID: 17516614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
    Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.
    Seki M; Ushiyama C; Seta N; Abe K; Fukazawa T; Asakawa J; Takasaki Y; Hashimoto H
    Arthritis Rheum; 1998 May; 41(5):823-30. PubMed ID: 9588733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.